Reviva Pharmaceuticals (RVPH) Q4 2025 Earnings

Nov 13Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-1.89
-1.3
-0.71
-0.12

Details

Expected EPS
-1.894571
Actual EPS
-1.2
Surprise EPS
0.69
Surprise Percent
+36.66%

Description

⁨Reviva Pharmaceuticals⁩ (⁦RVPH⁩) has reported earnings of ⁦-1.2⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts